IMPORTANT NOTICE: As you know, we have been closely monitoring the situation around the globe regarding the COVID-19 pandemic. The safety of all Molecular Pathology Economics Summit attendees is our first priority and we have made the difficult decision to cancel the 2020 Summit. The decision was made for the health and safety of our community and we appreciate having your continued support. Our thoughts continue to be with everyone affected by this pandemic. We plan to host the next Molecular Pathology Economics Summit in 2021 and are working now to plan for that event. Please check this page soon for updates.

AMP has compiled a list of COVID-19 resources, which we will continue to update as new information becomes available.

Molecular diagnostics is a rapidly evolving field with frequently changing standards for care that challenge the current paradigm for coding, coverage and payment. The Association for Molecular Pathology (AMP) is bringing together stakeholders across the healthcare spectrum in a one day summit with the goal to establish shared opportunities to improve the molecular diagnostics economic landscape.  Attendees will participate in guided discussions to identify barriers to appropriate reimbursement for molecular pathology procedures and then explore and have the opportunity to propose solutions to critical challenges that are limiting full realization of the possibilities offered by precision medicine. The Summit will connect experts across multiple industries and professional arenas harnessing the collective effort to advance the national dialogue towards improving patient access to appropriate molecular diagnostic care.

AMP’s Molecular Pathology Economics Summit will be a highly interactive one-day gathering focused on:

  • Identifying barriers to appropriate reimbursement for molecular pathology procedures;
  • Identifying the impact of these barriers on various stakeholders and patient access to care; and
  • Identifying potential solutions and/or novel approaches to overcoming barriers, with a goal of identifying shared policy agendas for the participating stakeholders in oncology, infectious diseases, and inherited conditions


Date: July 14, 2020
Time: 8:00am - 3:30pm Eastern
Location: InterContinental Washington D.C. - The Wharf, 801 Wharf St SW, Washington, DC 20024

Advanced Registration & Hotel Reservation Deadline: June 15, 2020

Program Chair & Facilitator

Program Chair
Samuel K. Caughron, MD
Chair, AMP Economic Affairs Committee
MAWD Pathology Group, P.A.


Program Facilitator
Amy M. Miller, PhD
President and CEO
Society for Women's Health Research



Agenda for the 2020 AMP Molecular Pathology Economics Summit Coming Soon

You can view the agenda for the 2019 AMP Molecular Pathology Economics Summit here


Summit Planning Committee

AMP Economic Affairs Committee Vice Chair: Coverage Decisions
Pranil Chandra, DO
PathGroup, LLC

AMP Economic Affairs Committee Vice Chair: New Codes and Pricing
Jay Patel, MD
ARUP Laboratories

AMP Economic Affairs Committee Past-Vice Chair: New Codes and Pricing
Anthony Sireci, MD, MSc
Loxo Oncology

AMP Economic Affairs Committee Member
Tanner Hagelstrom, PhD, MBA

AMP Economic Affairs Committee Member
Victoria Pratt, PhD
Indiana University Medical Center

AMP Economic Affairs Committee Junior Member
Salvatore Priore, MD, PhD
University of Pennsylvania

Registration Information

Information on registration will be coming soon!

Hotel & Travel Information

The 2020 AMP Molecular Pathology Economics Summit will be held at the Intercontinental DC at the Wharf. 

Hotel registration information is coming soon. 





For more information on becoming an Industry Partner for this event please contact, Laurie Menser.

Corporate Partners